UK markets open in 1 hour 17 minutes
NIKKEI 225
38,721.91 +485.84 (+1.27%) HANG SENG
18,468.06 -110.24 (-0.59%) CRUDE OIL
78.62 +0.14 (+0.18%) GOLD FUTURES
2,329.50 -1.70 (-0.07%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,459.18 -664.85 (-1.30%)
U.S. Physical Therapy, Inc. (USPH)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.60B |
| Enterprise value | 1.71B |
| Trailing P/E | 82.98 |
| Forward P/E | 41.32 |
| PEG ratio (5-yr expected) | 6.94 |
| Price/sales (ttm) | 2.49 |
| Price/book (mrq) | 3.36 |
| Enterprise value/revenue | 2.82 |
| Enterprise value/EBITDA | 22.94 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.38 |
| 52-week change 3 | -4.47% |
| S&P500 52-week change 3 | 24.49% |
| 52-week high 3 | 124.11 |
| 52-week low 3 | 78.08 |
| 50-day moving average 3 | 104.85 |
| 200-day moving average 3 | 97.79 |
Share statistics
| Avg vol (3-month) 3 | 72.31k |
| Avg vol (10-day) 3 | 58.14k |
| Shares outstanding 5 | 15.07M |
| Implied shares outstanding 6 | 15.56M |
| Float 8 | 14.81M |
| % held by insiders 1 | 1.66% |
| % held by institutions 1 | 105.34% |
| Shares short (15 Apr 2024) 4 | 619.71k |
| Short ratio (15 Apr 2024) 4 | 8.13 |
| Short % of float (15 Apr 2024) 4 | 5.52% |
| Short % of shares outstanding (15 Apr 2024) 4 | 4.11% |
| Shares short (prior month 15 Mar 2024) 4 | 745.89k |
Dividends & splits
| Forward annual dividend rate 4 | 1.76 |
| Forward annual dividend yield 4 | 1.66% |
| Trailing annual dividend rate 3 | 1.72 |
| Trailing annual dividend yield 3 | 1.63% |
| 5-year average dividend yield 4 | 1.27 |
| Payout ratio 4 | 134.38% |
| Dividend date 3 | 05 Apr 2024 |
| Ex-dividend date 4 | 11 Mar 2024 |
| Last split factor 2 | 3:2 |
| Last split date 3 | 29 Jun 2001 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 4.72% |
| Operating margin (ttm) | 10.84% |
Management effectiveness
| Return on assets (ttm) | 4.69% |
| Return on equity (ttm) | 6.55% |
Income statement
| Revenue (ttm) | 598.63M |
| Revenue per share (ttm) | 42.19 |
| Quarterly revenue growth (yoy) | 9.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 85.25M |
| Net income avi to common (ttm) | 18.14M |
| Diluted EPS (ttm) | 1.29 |
| Quarterly earnings growth (yoy) | -74.80% |
Balance sheet
| Total cash (mrq) | 155.49M |
| Total cash per share (mrq) | 10.32 |
| Total debt (mrq) | 258.59M |
| Total debt/equity (mrq) | 39.65% |
| Current ratio (mrq) | 2.28 |
| Book value per share (mrq) | 31.77 |
Cash flow statement
| Operating cash flow (ttm) | 81.98M |
| Levered free cash flow (ttm) | 65.97M |
© 2024 Yahoo. All rights reserved.